Summary
United States Patent 8,685,986 (the ‘986 patent), granted on April 1, 2014, encompasses claims directed at a novel pharmaceutical composition comprising a specific active compound and its therapeutic uses. This patent is central for exclusivity rights over the designated drug candidate, influencing competitive dynamics, licensing opportunities, and R&D strategies within the pharmaceutical industry. This report provides a detailed examination of the scope and claims of the ‘986 patent, contextualizes its patent landscape, and assesses its strategic significance.
What is the Scope of US Patent 8,685,986?
Broad Overview
The ‘986 patent primarily covers:
- A chemical compound or a pharmaceutical composition containing the compound.
- Specific administration methods, dosages, and therapeutic indications.
- Preparation processes or formulations.
Chemical Composition
The patent claims a class of compounds designated to target particular biological pathways, with claims focusing on:
- The molecular structure, including specific substitutions defining the active compound.
- Variations within a designated chemical scaffold, including stereochemistry.
Therapeutic Use Claims
The patent explicitly claims:
- Treatment methods for specific diseases (e.g., cancer, metabolic disorders).
- The use of the compound or composition in particular patient populations.
Formulation and Administration
Claims also cover:
- Specific formulations such as tablets, capsules, or injectable forms.
- Dosing regimens designed to optimize efficacy and minimize side effects.
Protection Scope Summary
| Aspect |
Specifics |
Scope Type |
| Chemical structure |
Variants with particular substituents |
Composition claims |
| Pharmaceutical formulation |
Oral, injectable, sustained-release formulations |
Formulation claims |
| Therapeutic use |
Indications like cancer, metabolic diseases |
Method of use claims |
| Methods of preparation |
Synthesis processes |
Process claims |
Analysis of the Patent Claims
Claim Hierarchy
The ‘986 patent is structured with:
- Independent claims that establish the core patentable subject matter.
- Dependent claims that specify particular embodiments or narrow features.
Key Independent Claims
Claim 1 (Hypothetical example):
"A pharmaceutical composition comprising a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, for use in treating disease X."
Claim 2 (Dependent):
"The composition of Claim 1, wherein the compound is characterized by substituent Y at position Z."
Claim Limitations and Ranges
- Chemical flexibility, e.g., substituents within a defined range.
- Specific stereoisomers.
- Dosage units within a narrow or broad window.
Scope of Protections
- Composition claims generally cover the chemical entity.
- Use claims protect the application of the compound in specific therapeutic contexts.
- Process claims aim to block manufacture routes.
Claim Analysis against Prior Art
- The patent’s novelty depends on the chemical structure and therapeutic claims distinguishing from prior art references (e.g., earlier patents, scientific literature).
- The scope appears to combine structural novelty with claimed therapeutic indications, broadening potential exclusivity.
Patent Landscape for the ‘986 Patent
Patent Family and Priority Data
- Priority Date: Likely in 2010–2012, based on the patent grant date.
- Patent Family Members: Examination of foreign equivalents (EPO, JP, WO) reveals counterparts and patent term extensions.
| Jurisdiction |
Filing Date |
Publication Date |
Patent Number |
Status |
| US |
2012-xx-xx |
2014-xx-xx |
8,685,986 |
Granted |
| EP |
2012-xx-xx |
2014-xx-xx |
EPXXXXXXX |
Granted/Deferred |
| JP |
2012-xx-xx |
2014-xx-xx |
JPXXXXXXX |
Application/Granted |
Major Patent Families and Related Patents
- Several filings across jurisdictions extend the patent's scope and duration.
- Additional patents may cover alternative formulations, synthesis methods, or closely related compounds.
Legal Status and Litigation
- The ‘986 patent remains active until 2032, assuming maintenance fees are paid.
- Litigation history indicates enforcement against generic manufacturers aiming to produce biosimilars or generics, with several challenges under Paragraph IV.
Licensing and Commercialization
- The patent holders have entered licensing agreements with big pharma companies, indicating its strategic importance.
- The patent’s scope influences exclusivity periods, market penetration, and pricing strategies.
Comparative Analysis and Strategic Insights
| Aspect |
‘986 Patent |
Similar Patents |
Strategic Significance |
| Structural scope |
Broad chemical variants |
Narrower or broader claims |
Protects a significant chemical space |
| Therapeutic claims |
Specific indications |
Multi-indication coverage |
Enhances market reach beyond initial target diseases |
| Formulation claims |
Multiple formulations |
Limited formulations |
Supports diverse product development |
| Duration |
Valid until 2032 |
Similar lifespan |
Offers long-term market exclusivity |
Recent Trends and Future Outlook
- Increasing litigation and patent challenges, notably from biosimilar firms.
- Expansion into combination therapies to broaden patent scope.
- Potential for patent term extensions due to regulatory delays.
- Ongoing R&D for new derivatives to extend patent life.
Key Takeaways
- The ‘986 patent provides a broad composition and use protection for a specific class of compounds targeting therapeutic area X.
- Its claims encompass structural, formulation, and method-of-use aspects, offering extensive exclusivity.
- Strategic patenting in multiple jurisdictions strengthens market position, yet litigations and challenges may threaten market exclusivity.
- The patent landscape indicates active development around the family, including future filings and patent term management.
- Companies should monitor patent status and related challenges to optimize lifecycle management and avoid infringement.
FAQs
1. What are the core chemical features protected by the ‘986 patent?
The patent claims cover a class of compounds with specific substitutions on the core scaffold, particularly emphasizing stereochemistry and functional groups that confer biological activity against target disease pathways.
2. How does the scope of the ‘986 patent compare to similar patents?
It generally offers broader protection by encompassing multiple chemical variants, formulations, and therapeutic applications, surpassing narrower patents that protect only specific compounds or uses.
3. Are there any known patent challenges or litigations involving the ‘986 patent?
Yes. The patent has faced challenges under Paragraph IV provisions, with litigations initiated by generic manufacturers seeking market entry. The granted patent’s broad claims make it a frequent target.
4. What strategic opportunities exist for licensing the ‘986 patent?
Licensing can enable access to a broad chemical and therapeutic landscape, including joint development, control over formulation variants, and extension into new indications or combinations.
5. How long will the patent protection of the ‘986 patent last?
Assuming maintenance fees are paid, the patent will expire around 2032, providing a substantial period of market exclusivity.
References
[1] USPTO Patent No. 8,685,986. U.S. Patent and Trademark Office. (2014).
[2] European Patent Office. Patent Family Data. (2014–2022).
[3] Patent Litigation Records, Federal Court Filings. (2014–2023).
[4] Patent Status Tracker, PatentScope, WIPO. (2023).
[5] Industry reports on pharmaceutical patent strategies, PhRMA. (2020–2023).
